Loading...
•
Mar 31, 2023
OptimizeRx Q1 2023 Earnings Report
Reported first quarter 2023 financial results.
Key Takeaways
OptimizeRx reported a solid start to 2023 with total revenue of $13.0 million. The company's execution remains on pace to meet its 2023 financial and operational objectives.
Total revenue was $13.0 million.
GAAP net loss per share was $(0.37).
Non-GAAP net loss per share was $(0.09).
Reaffirmed full year financial outlook for net revenue to increase at least 10% year-over-year.
Forward Guidance
The Company is reaffirming its full year financial outlook for fiscal 2023 for net revenue to increase at least 10% year-over-year, and gross margins to be between 58% and 62%.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...